A 51-year-old man noticed abdominal swelling and distention with intermittent abdominal pain, early satiety, and decreased appetite over the past several months. A computed tomography scan of the abdomen is performed. What's your diagnosis?
Mehmet Sitki Copur, MD
The 2019 American Society of Clinical Oncology (ASCO) Annual Meeting, which took place May 31–June 4 in Chicago, drew more than 32,000 oncology specialists from around the world.
The US Food and Drug Administration recently approved a new indication for olaparib for maintenance treatment in adult patients with germline or somatic BRCA-mutated advanced epithelial ovarian cancer.
Background: Acute myeloid leukemia (AML) is a malignancy of the bone marrow in which development of hematopoietic precursors halts during early stages of marrow formation.
This article reviews the current state of cancer research around the world.
This article reviews patient requests and how they may be in contrast with guidelines, and provides recommendations from a community oncology practice perspective.
Inadequate Awareness of and Participation in Cancer Clinical Trials in the Community Oncology Setting
In this article, we discuss why participation in clinical trials in the community oncology setting is often inadequate, how this affects cancer research, and the ways to close this gap.
In this case, we examine a 49-year-old man with widespread metastatic sclerotic bone lesions. What is your diagnosis?
This lesion started as a rash 3 months prior to presentation and became an ulcerated open wound with some nodularity in and around it. What is your diagnosis?
Are there special second-line considerations for an SCC lung patient with a history of Crohn disease who progressed on first-line carboplatin and gemcitabine? Can any pretreatment tests be deferred for a patient with a history of heavy smoking and a single solitary nodule found on his CT chest scan? Take this multiquestion quiz to find out.